BOLD Capital Partners

#ICYMI: Our Chief Clinical Officer, Ben Green, MD Green, joined American Heart Association’s Center for Health Technology & Innovation (CHTI) for a great conversation on the latest sensor capabilities in remote monitoring and strategies for integrating patient-generated data into clinical workflows. 🏥 🎥💡Catch the full webinar recording: https://lnkd.in/gdZbh-Va #AHACHTI #aha26 #AHACHTIwebinars #ahahealthtech #HealthTech #DigitalHealth #webinar #MedTech

The new Evergreen website is now live. This marks an exciting milestone for our company and the meat industry. Our mission is to create year-round stability in a market defined by volatility. If you’re a beef producer or operator seeking scalable solutions for supply, quality, and pricing, we’re excited to partner with you. Welcome to the predictable future of beef. https://evergreen.food/

Exciting news: today we are launching a groundbreaking new product within our unified eClinical Platform. Introducing the Curebase Fax Machine: The Fax Solution Clinical Research Has Been Waiting For! San Francisco, CA — April 1, 2026 — Curebase, the unified eClinical platform built for modern clinical research, today announced the launch of the Curebase Fax Machine, joining the product suite alongside ePRO/eCOA, eConsent, Recruitment, participant engagement tools, and more. We heard the feedback: clinical trials need more innovation. And that is exactly what we are setting out to achieve. The Curebase Fax Machine features include: ✅ GDPR-compliant toner ✅ Thermal paper EDC integration ✅ Real-time fax tracking (please allow 3-5 business days) ✅ AI busy-signal detection ✅ Automatic cover sheet generation "Our customers have been asking for better communication tools," said Storm Stillman, CEO of Curebase. "We already have a full campaign suite for clinical trial participant engagement across landing pages, email, and SMS. Bringing on the Curebase Fax Machine is the natural next step." Find out more 👉 https://lnkd.in/g4i_tfyh #CurebaseFaxMachine #eClinical #AprilFoolsDay

Recent U.S. Food and Drug Administration (FDA) guidance on “QTc Information in Drug Labeling" underscores a clear shift – rigorous ECG monitoring for QTc prolongation risk is more critical than ever. To safely manage these risks and make necessary dosage modifications, the FDA recommends assessing QTc  at baseline, periodically during treatment, and whenever clinically indicated. But relying solely on traditional, site-based in-clinic ECGs to meet these expectations  is expensive, limits scalability, and places a significant burden on trial participants. Furthermore, fleeting symptoms like palpitations or dizziness are often missed if patients have to wait for in-person appointments. At AliveCor, we help sponsors close these gaps by capturing medical-grade, 6-lead ECGs remotely, while also enabling rapid, point-of-care QTc measurement. Our technology allows you to: ✅ Meet FDA Monitoring Guidance: Seamlessly collect baseline and on-treatment ECGs remotely. ✅ Make Real-Time Dosing Decisions: Get accurate, timely QTc data required to safely adjust or withhold dosages. ✅ Capture Symptomatic Events Instantly: Allow patients to record an ECG at the exact moment they experience a symptom, ensuring you never miss critical safety data. Is your clinical operations team prepared to meet the updated QTc monitoring expectations– efficiently and at scale? Let’s connect: https://lnkd.in/gfXnZF5S #ClinicalTrials #Pharma #FDAGuidance #DrugDevelopment #Cardiology #DecentralizedTrials #DigitalHealth

We're proud to be included in the WOW Health - World of Women's Health Market Map — and more proud of why we're there. The window to protect bone density opens early and closes quietly. Most women never know they missed it. Bōndia exists to change that. A plant-sourced synbiotic medical food, clinically proven in a 12-month randomized, double-blind, placebo-controlled trial — reducing bone loss by up to 85% in postmenopausal women with osteopenia. Being recognized in the women's health ecosystem matters. But what matters more: women getting ahead of bone loss before it stops them. This is what we're here for. View the Market Map here: https://www.wowhealth.co/ (search for Bondia)

So great to see our new collab with Ashu's Matcha - The Ceremony Matcha Mask - feauted in Condé Nast's BONAPPETIT magazine. Our first collaboration with another brand - this one feels special: rich in polyphenol ceremonial grade matcha is paired with Symbiome's bioactive fermented oils, creating a one-of-a-kind face mask that is able to effectively neutralize free radicals, reducing inflammation and anti-oxidant stress at the cellular level. Could not have been done without our brilliant Chief Scientific Officer Larry Weiss, MD https://lnkd.in/edCCSvXY

https://lnkd.in/gYi6GAiT

We're excited to announce a new partnership with Tech Mahindra today. Together, we're bringing AI-powered digital supply chain solutions to global enterprises. This partnership aims to enhance resilience and agility through AI-driven solutions that provide greater visibility and enable proactive decision-making across supply chains, particularly in the pharmaceutical and cold-chain logistics sectors. This is a meaningful step forward in helping companies move from insight to action across increasingly complex supply chains. Read the announcement here: https://lnkd.in/gzz2D523